BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.

BNT162b2 against COVID-19 in Brazil using a test-negative design: Study protocol and statistical analysis plan.

Show other versions (1)

<h4>Introduction</h4>Real-world data on COVID-19 vaccine effectiveness are needed to validate evidence from randomized clinical trials. Accordingly, this study aims to evaluate, in a real-world setting in Brazil, the effectiveness of Pfizer-BioNTech BNT162b2 against symptomatic COVID-19...

Full description

Bibliographic Details
Main Authors: Regis Goulart Rosa, Julia Spinardi, Kristen E Allen, Josélia Manfio, Cintia Laura Pereira de Araujo, Mírian Cohen, Caroline Cabral Robinson, Daniel Sganzerla, Diogo Ferreira, Emanuel Maltempi de Souza, Jaqueline Carvalho de Oliveira, Daniela Fiori Gradia, Ana Paula Carneiro Brandalize, Gabriela Almeida Kucharski, Fernando Pedrotti, Cristina de Oliveira Rodrigues, Moe H Kyaw, Graciela Del Carmen Morales Castillo, Amit Srivastava, John M McLaughlin, Maicon Falavigna
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0276384

Internet

https://doi.org/10.1371/journal.pone.0276384

Similar Items